Search

Michael G. Hartley

Supervisory Patent Examiner (ID: 10970, Phone: (571)272-0616 , Office: P/1618 )

Most Active Art Unit
1616
Art Unit(s)
1211, 1618, 1619, 1616, 1621
Total Applications
1070
Issued Applications
502
Pending Applications
296
Abandoned Applications
273

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18628343 [patent_doc_number] => 20230287205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS [patent_app_type] => utility [patent_app_number] => 18/181675 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181675 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/181675
Dissolvable solid structure having first and second layers Mar 9, 2023 Issued
Array ( [id] => 19417220 [patent_doc_number] => 20240293343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications [patent_app_type] => utility [patent_app_number] => 18/109031 [patent_app_country] => US [patent_app_date] => 2023-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109031 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/109031
Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications Feb 12, 2023 Pending
Array ( [id] => 18389961 [patent_doc_number] => 20230158179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/989479 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/989479
RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF Nov 16, 2022 Abandoned
Array ( [id] => 17836269 [patent_doc_number] => 20220273574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/748432 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748432 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748432
ORGANIC COMPOUNDS May 18, 2022 Abandoned
Array ( [id] => 17760016 [patent_doc_number] => 20220233628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/712479 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712479
PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE Apr 3, 2022 Pending
Array ( [id] => 17827930 [patent_doc_number] => 20220265234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => Radiographic Contrast Agents For Temporal Subtraction And Dual-Energy X-Ray Imaging [patent_app_type] => utility [patent_app_number] => 17/711156 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711156 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711156
Radiographic contrast agents for temporal subtraction and dual-energy x-ray imaging Mar 31, 2022 Issued
Array ( [id] => 17702959 [patent_doc_number] => 20220202965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => RADIOTRACER COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/695810 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/695810
RADIOTRACER COMPOSITIONS AND METHODS Mar 14, 2022 Abandoned
Array ( [id] => 20729142 [patent_doc_number] => 12636386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-26 [patent_title] => Compositions and methods for the treatment and imaging of cancer [patent_app_type] => utility [patent_app_number] => 17/689200 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 10029 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689200 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/689200
Compositions and methods for the treatment and imaging of cancer Mar 7, 2022 Issued
Array ( [id] => 17593656 [patent_doc_number] => 20220143229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => RADIO-PHARMACEUTICAL COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/581808 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581808
RADIO-PHARMACEUTICAL COMPLEXES Jan 20, 2022 Abandoned
Array ( [id] => 18253444 [patent_doc_number] => 20230080483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => MTORC MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/553409 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553409
mTORC modulators and uses thereof Dec 15, 2021 Issued
Array ( [id] => 17671072 [patent_doc_number] => 20220184239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS [patent_app_type] => utility [patent_app_number] => 17/539442 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/539442
METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS Nov 30, 2021 Pending
Array ( [id] => 17671067 [patent_doc_number] => 20220184234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METABOLIC TARGETING OF LOW GRADE TUMORS [patent_app_type] => utility [patent_app_number] => 17/537029 [patent_app_country] => US [patent_app_date] => 2021-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/537029
METABOLIC TARGETING OF LOW GRADE TUMORS Nov 28, 2021 Abandoned
Array ( [id] => 17658456 [patent_doc_number] => 20220178921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/454300 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/454300
4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF Nov 9, 2021 Abandoned
Array ( [id] => 17342234 [patent_doc_number] => 20220008565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => Enhanced in Vivo Targeting of Site-Specific Drugs [patent_app_type] => utility [patent_app_number] => 17/484727 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/484727
Enhanced in Vivo Targeting of Site-Specific Drugs Sep 23, 2021 Pending
Array ( [id] => 17183934 [patent_doc_number] => 20210330819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/365733 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12379 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/365733
DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES Jun 30, 2021 Pending
Array ( [id] => 18319731 [patent_doc_number] => 20230117859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => INHALED XENON THERAPY IN NEURODEGENERATIVE DISEASE [patent_app_type] => utility [patent_app_number] => 17/914061 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914061 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914061
INHALED XENON THERAPY IN NEURODEGENERATIVE DISEASE Mar 24, 2021 Abandoned
Array ( [id] => 16930696 [patent_doc_number] => 20210196585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => BIODEGRADABLE MICROBEADS [patent_app_type] => utility [patent_app_number] => 17/199950 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199950 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199950
BIODEGRADABLE MICROBEADS Mar 11, 2021 Abandoned
Array ( [id] => 20491453 [patent_doc_number] => 12533308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Water-dispersible, oil-free, and UV-blocking cosmetic composition and preparation method therefor [patent_app_type] => utility [patent_app_number] => 17/798238 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/798238
Water-dispersible, oil-free, and UV-blocking cosmetic composition and preparation method therefor Feb 8, 2021 Issued
Array ( [id] => 16779410 [patent_doc_number] => 20210116488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors [patent_app_type] => utility [patent_app_number] => 17/109010 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109010 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109010
Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors Nov 30, 2020 Abandoned
Array ( [id] => 20465347 [patent_doc_number] => 12521376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Gel-chewable dosage form [patent_app_type] => utility [patent_app_number] => 17/753648 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1185 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753648
Gel-chewable dosage form Sep 14, 2020 Issued
Menu